Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Intrauterine environment and multiple sclerosis: a population- based case-control study.
A nurse-led mental health service for people with multiple sclerosis.
[New treatment options in multiple sclerosis and their complications].
Modulation of CNS autoimmune responses by CD8(+) T cells coincides with their oligoclonal expansion.
[American Academy of Neurology, Washington, 18-25 April 2015].
Evidence for a two-stage disability progression in multiple sclerosis.
Glutamate inhibition in MS: the neuroprotective properties of riluzole.
Cerebrospinal fluid analysis.
Fingolimod (Gilenya) licence extended
Closing the clinical-radiological paradox using the visual pathway in multiple sclerosis.
Evaluating treatment effect within a multivariate stochastic ordering framework: Nonparametric combination methodology applied to a study on multiple sclerosis.
Neurologic complications of influenza.
IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation.
Interleukin-17- and interleukin-22-secreting myelin-specific CD4(+) T cells resistant to corticoids are related with active brain lesions in multiple sclerosis patients.
Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
Integrated clinical and specialty pharmacy practice model for management of patients with multiple sclerosis.
Glycans of myelin proteins.
Lack of response to rituximab therapy in patients with neuromyelitis optica: Response to Kim and Kim.
Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity.
Home-based exercise program and fall-risk reduction in older adults with multiple sclerosis: phase 1 randomized controlled trial.
Multiple Sclerosis Disease Progression and Paradichlorobenzene: A Tale of Mothballs and Toilet Cleaner.
Cyclical suicidal ideation following natalizumab infusion for multiple sclerosis.
Antidepressant activity of fingolimod in mice.
Experimental RRMS Therapy to Be Tested in a Phase 2b Clinical Trial
B cell exchange across the blood-brain barrier in multiple sclerosis.

Pages